PT91154A - Processo para a preparacao de ergolinas substituidas na posicao 2 e de composicoes farmaceuticas que as contem - Google Patents

Processo para a preparacao de ergolinas substituidas na posicao 2 e de composicoes farmaceuticas que as contem

Info

Publication number
PT91154A
PT91154A PT91154A PT9115489A PT91154A PT 91154 A PT91154 A PT 91154A PT 91154 A PT91154 A PT 91154A PT 9115489 A PT9115489 A PT 9115489A PT 91154 A PT91154 A PT 91154A
Authority
PT
Portugal
Prior art keywords
alkyl
substituted
hydrogen
ergolins
preparation
Prior art date
Application number
PT91154A
Other languages
English (en)
Other versions
PT91154B (pt
Inventor
Gerhard Sauer
Thomas Brumby
Helmut Dr Wachtel
Jonathan Turner
Josef Heindel
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19883824661 external-priority patent/DE3824661A1/de
Priority claimed from DE19893917268 external-priority patent/DE3917268A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of PT91154A publication Critical patent/PT91154A/pt
Publication of PT91154B publication Critical patent/PT91154B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT91154A 1988-07-15 1989-07-13 Processo para a preparacao de ergolinas substituidas na posicao 2 e de composicoes farmaceuticas que as contem PT91154B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19883824661 DE3824661A1 (de) 1988-07-15 1988-07-15 2'-substituierte 3-(8'(alpha)-ergolinyl)-1,1-diethylharnstoffe bzw. -thioharnstoffe, ihre herstellung und verwendung als zwischenprodukte sowie in arzneimitteln
DE19893917268 DE3917268A1 (de) 1989-05-23 1989-05-23 2-substituierte ergoline, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
PT91154A true PT91154A (pt) 1990-02-08
PT91154B PT91154B (pt) 1995-01-31

Family

ID=25870307

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91154A PT91154B (pt) 1988-07-15 1989-07-13 Processo para a preparacao de ergolinas substituidas na posicao 2 e de composicoes farmaceuticas que as contem

Country Status (10)

Country Link
US (2) US5037832A (pt)
EP (1) EP0351352B1 (pt)
JP (1) JPH02142790A (pt)
AT (1) ATE119529T1 (pt)
CA (1) CA1339584C (pt)
DE (1) DE58909077D1 (pt)
DK (1) DK338789A (pt)
ES (1) ES2072917T3 (pt)
HU (1) HU211486A9 (pt)
PT (1) PT91154B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242678A (en) * 1986-07-10 1993-09-07 Schering Aktiengesellschaft BR*-diagnostics for monoamine receptors
DK338789A (da) * 1988-07-15 1990-01-16 Schering Ag 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf
PT99864B (pt) * 1990-12-21 1999-06-30 Schering Ag Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato
AU1226192A (en) * 1991-02-08 1992-09-07 Schering Aktiengesellschaft Process for producing ergolin derivatives
DE4123587A1 (de) * 1991-07-12 1993-01-14 Schering Ag 2,14-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln
DE4343920A1 (de) * 1993-12-22 1995-06-29 Hoechst Ag Filter zur Entfernung von Stickoxiden aus Tabakrauch
SG181896A1 (en) * 2009-12-23 2012-07-30 Map Pharmaceuticals Inc Novel ergoline analogs
KR20140042868A (ko) 2011-06-23 2014-04-07 맵 파마슈티컬스, 인코포레이티드 신규한 플루오로에르골린 유사체
SG10201509139QA (en) 2011-12-19 2015-12-30 Map Pharmaceuticals Inc Novel iso-ergoline derivatives
SG11201403433PA (en) 2011-12-21 2014-07-30 Map Pharmaceuticals Inc Novel neuromodulatory compounds
CN104822264A (zh) * 2012-06-22 2015-08-05 Map药物公司 新的卡麦角林衍生物
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
US20140179707A1 (en) * 2012-12-21 2014-06-26 Map Pharmaceuticals, Inc. Novel ergoline derivatives and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0021206B1 (de) * 1979-06-13 1983-06-22 Schering Aktiengesellschaft Neue (Ergolin-yl)-N', N'-diäthylharnstoff-Derivate, ihre Herstellung und sie enthaltende Arzneimittel
DE3151912A1 (de) * 1981-12-23 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE3309493A1 (de) * 1983-03-14 1984-09-20 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel
PH21123A (en) * 1983-04-28 1987-07-27 Erba Farmitalia Ergoline derivatives
HU197569B (en) * 1984-01-12 1989-04-28 Sandoz Ag Process for producing 8alpha-acylaminoergoline derivatives and pharmaceuticals comprising such compounds
DE3411981A1 (de) * 1984-03-28 1985-10-10 Schering AG, Berlin und Bergkamen, 1000 Berlin Verfahren zur herstellung von 2.3-dihydroergolinen
DE3413659A1 (de) * 1984-04-09 1985-10-17 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 2-substituierte ergolin-derivate
ATE107647T1 (de) * 1984-04-09 1994-07-15 Schering Ag 2-substituierte ergolin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
CH666035A5 (de) * 1984-12-24 1988-06-30 Sandoz Ag 8-alpha-acylaminoergolene.
DE3533672A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-substituierte ergolinderivate
DE3533675A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-brom-ergolinderivate
DE3535929A1 (de) * 1985-10-04 1987-04-09 Schering Ag 1,2-disubstituierte ergolinderivate
DE3535930A1 (de) * 1985-10-04 1987-04-09 Schering Ag Neue 2-substituierte ergolinderivate
NL8700046A (nl) * 1986-01-24 1987-08-17 Sandoz Ag 8 alfa-acylaminoergolinen, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten.
DE3620293A1 (de) * 1986-06-16 1987-12-17 Schering Ag 1-und/oder 2-substituierte ergolinderivate
DE3623438C2 (de) * 1986-07-10 1998-04-09 Schering Ag In 2-Stellung mit radioaktivem Iod markierte Ergolinylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Diagnostika
DE3623437C2 (de) * 1986-07-10 1998-04-09 Schering Ag In 2-Stellung mit radioaktivem Brom markierte Ergolinylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Diagnostika
DE3708028A1 (de) * 1987-03-10 1988-09-22 Schering Ag Verfahren zur herstellung von 2,3ss-dihydroergolinen, 2-substituierte 2,3ss-dihydroergoline und ihre verwendung als arzneimittel
DK338789A (da) * 1988-07-15 1990-01-16 Schering Ag 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf

Also Published As

Publication number Publication date
PT91154B (pt) 1995-01-31
ATE119529T1 (de) 1995-03-15
US5158957A (en) 1992-10-27
CA1339584C (en) 1997-12-16
ES2072917T3 (es) 1995-08-01
JPH02142790A (ja) 1990-05-31
EP0351352A3 (de) 1991-07-03
HU211486A9 (en) 1995-11-28
DE58909077D1 (de) 1995-04-13
DK338789D0 (da) 1989-07-07
DK338789A (da) 1990-01-16
EP0351352A2 (de) 1990-01-17
US5037832A (en) 1991-08-06
EP0351352B1 (de) 1995-03-08

Similar Documents

Publication Publication Date Title
PT91154A (pt) Processo para a preparacao de ergolinas substituidas na posicao 2 e de composicoes farmaceuticas que as contem
PT1229040E (pt) Derivados nucleosido-monofosfato processo para a sua producao e sua utilizacao como farmacos imunossupressores
BR9906799A (pt) Composto, processo de tratamento de uma condição hiperlipidêmica em um mamìfero, composição farmacêutica, e, processo para a preparação de um composto
SE9502244D0 (sv) A composition and a process for the preparation thereof
KR890011601A (ko) (사이클로알킬아미노)메틸렌비스(포스폰산)및 활성성분으로서 이를 함유한 의약
ES2014220B3 (es) Nuevos derivados de acido difosfonico, procedimiento para su preparacion y medicamentos que contienen estos compuestos.
FR2430410A1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
NZ331941A (en) Pentafluorobenzenesulfonamides and analogs and use in regulation of LDL receptor synthesis
FI854227L (fi) Menetelmä analgeettisena aineena käyttökelpoisten polypeptidien valmistamiseksi
DE59002863D1 (de) Lysolecithinderivate zur behandlung von autoimmunerkrankungen.
ES2111269T3 (es) Procedimiento de extraccion de compuestos malolientes presentes en una formulacion que contiene al menos un compuesto que comprende un grupo tiol y composiciones desodorizadas asi obtenidas.
HUP9802206A1 (hu) Thalidomid intravénás adagolási formája immunológiai megbetegedések gyógyításához
PT81786B (pt) Processo para a preparacao de inibidores da dopamina-beta-hidroxilase
IT1190378B (it) Derivati pirrolidonici
SE8303385D0 (sv) 1,4-dihydropyridine derivatives, in optically active or in racemate form and their production and pharmaceutical compositions
PT88088A (pt) Processo para a preparacao de derivados de piperidina e de composicoes farmaceuticas que os contem
ATE24716T1 (de) Lenkotrien-antagonisten.
KR920701232A (ko) 신규 9α-히드록시-3-옥소-4,24(25)-스티그마스타디엔-26-산 유도체, 이의 제조법 및 이를 함유하는 약학 조성물
PE6691A1 (es) Tetrahidrobenzopiranopirazoles artropodicidas
FR2447377A1 (fr) 25-hydroxycholecalciferol-26,23-lactone et composition pharmaceutique renfermant ce produit
PT89781A (pt) Processo para a preparacao de composicoes farmaceuticas de aplicacao intradermica de heparina
BR9611805A (pt) Derivados de amino álcool processos para a sua produção e agentes farmacêuticos contendo estes compostos
SE8303410D0 (sv) Benzene derivatives, processes for their preparation and pharmaceutical compositions comprising them
BR8807291A (pt) Composicao lubrificante,concentrado,material fibroso tendo concentrado e processo para preparar aditivo de lubrificante de fibra de fiar

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940721

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20000131